UOC
ETNB

UBS O'Connor’s 89bio ETNB Stock Holding History

UBS O'Connor’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,962
Closed -$419K – 575
2024
Q1 		$419K Sell
35,962
-43,113
-55% -$477K 0.01% 345
2023
Q4 		$883K Sell
79,075
-19,763
-20% -$182K 0.03% 287
2023
Q3 		$1.53M Buy
98,838
+15,000
+18% +$252K 0.03% 279
2023
Q2 		$1.59M Buy
83,838
+27,899
+50% +$490K 0.03% 330
2023
Q1 		$852K Buy
+55,939
New +$729K 0.02% 426
2022
Q4 		– Sell
-92,034
Closed -$533K – 111
2022
Q3 		$533K Buy
+92,034
New +$404K 0.01% 809

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

UBS O'Connor's ETNB Position: Q2 2024 in Review

UBS O'Connor sold out of 89bio (ETNB) in Q2 2024, closing a stake of 35,962 shares — an estimated $419K sold.

UBS O'Connor first reported a position in ETNB in Q3 2022 and held it in 6 quarters. The position peaked at $1.59M in Q2 2023. 145 funds tracked by Wall St. Rank hold ETNB as of Q2 2024.

  • UBS O'Connor reported no remaining 89bio position as of Q2 2024 after selling out during the quarter.
  • UBS O'Connor sold 35,962 89bio shares in Q2 2024, an estimated $419K.
  • UBS O'Connor first reported a position in 89bio in Q3 2022 and held it in 6 quarters.
  • UBS O'Connor's 89bio position peaked at $1.59M in Q2 2023.
  • 145 funds tracked by Wall St. Rank held 89bio as of Q2 2024.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.